Multi-loaded PLGA microspheres as neuroretinal therapy in a chronic glaucoma animal model Article Swipe
Alba Aragón-Navas
,
María Jesús Rodrigo
,
Inés Munuera
,
David García-Herranz
,
Manuel Subías
,
Pilar Villacampa
,
J. García–Sánchez
,
Luís E. Pablo
,
Elena García‐Martín
,
Rocío Herrero‐Vanrell
,
Irene Bravo‐Osuna
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1007/s13346-024-01702-x
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1007/s13346-024-01702-x
Related Topics
Concepts
PLGA
Glial cell line-derived neurotrophic factor
Glaucoma
In vivo
Neuroprotection
Dexamethasone
Glycolic acid
Poloxamer
Intravitreal administration
Chemistry
Biomedical engineering
Neurotrophic factors
Pharmacology
Chromatography
Materials science
Medicine
Ophthalmology
Lactic acid
Retinal
Biochemistry
In vitro
Organic chemistry
Copolymer
Genetics
Endocrinology
Biology
Receptor
Biotechnology
Bacteria
Polymer
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1007/s13346-024-01702-x
- OA Status
- hybrid
- Cited By
- 2
- References
- 65
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4403097769
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4403097769Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1007/s13346-024-01702-xDigital Object Identifier
- Title
-
Multi-loaded PLGA microspheres as neuroretinal therapy in a chronic glaucoma animal modelWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-10-03Full publication date if available
- Authors
-
Alba Aragón-Navas, María Jesús Rodrigo, Inés Munuera, David García-Herranz, Manuel Subías, Pilar Villacampa, J. García–Sánchez, Luís E. Pablo, Elena García‐Martín, Rocío Herrero‐Vanrell, Irene Bravo‐OsunaList of authors in order
- Landing page
-
https://doi.org/10.1007/s13346-024-01702-xPublisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1007/s13346-024-01702-xDirect OA link when available
- Concepts
-
PLGA, Glial cell line-derived neurotrophic factor, Glaucoma, In vivo, Neuroprotection, Dexamethasone, Glycolic acid, Poloxamer, Intravitreal administration, Chemistry, Biomedical engineering, Neurotrophic factors, Pharmacology, Chromatography, Materials science, Medicine, Ophthalmology, Lactic acid, Retinal, Biochemistry, In vitro, Organic chemistry, Copolymer, Genetics, Endocrinology, Biology, Receptor, Biotechnology, Bacteria, PolymerTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2Per-year citation counts (last 5 years)
- References (count)
-
65Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4403097769 |
|---|---|
| doi | https://doi.org/10.1007/s13346-024-01702-x |
| ids.doi | https://doi.org/10.1007/s13346-024-01702-x |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39361228 |
| ids.openalex | https://openalex.org/W4403097769 |
| fwci | 2.38957276 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000818 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Animals |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000077182 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Polylactic Acid-Polyglycolic Acid Copolymer |
| mesh[2].qualifier_ui | Q000188 |
| mesh[2].descriptor_ui | D005901 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | drug therapy |
| mesh[2].descriptor_name | Glaucoma |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D008863 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Microspheres |
| mesh[4].qualifier_ui | Q000008 |
| mesh[4].descriptor_ui | D018696 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | administration & dosage |
| mesh[4].descriptor_name | Neuroprotective Agents |
| mesh[5].qualifier_ui | Q000737 |
| mesh[5].descriptor_ui | D018696 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | chemistry |
| mesh[5].descriptor_name | Neuroprotective Agents |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D004195 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Disease Models, Animal |
| mesh[7].qualifier_ui | Q000008 |
| mesh[7].descriptor_ui | D003907 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | administration & dosage |
| mesh[7].descriptor_name | Dexamethasone |
| mesh[8].qualifier_ui | Q000737 |
| mesh[8].descriptor_ui | D003907 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | chemistry |
| mesh[8].descriptor_name | Dexamethasone |
| mesh[9].qualifier_ui | Q000737 |
| mesh[9].descriptor_ui | D011100 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | chemistry |
| mesh[9].descriptor_name | Polyglycolic Acid |
| mesh[10].qualifier_ui | Q000008 |
| mesh[10].descriptor_ui | D011100 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | administration & dosage |
| mesh[10].descriptor_name | Polyglycolic Acid |
| mesh[11].qualifier_ui | Q000737 |
| mesh[11].descriptor_ui | D019344 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | chemistry |
| mesh[11].descriptor_name | Lactic Acid |
| mesh[12].qualifier_ui | Q000008 |
| mesh[12].descriptor_ui | D019344 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | administration & dosage |
| mesh[12].descriptor_name | Lactic Acid |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D051381 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Rats |
| mesh[14].qualifier_ui | Q000008 |
| mesh[14].descriptor_ui | D051100 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | administration & dosage |
| mesh[14].descriptor_name | Glial Cell Line-Derived Neurotrophic Factor |
| mesh[15].qualifier_ui | Q000737 |
| mesh[15].descriptor_ui | D051100 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | chemistry |
| mesh[15].descriptor_name | Glial Cell Line-Derived Neurotrophic Factor |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D008297 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Male |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D065546 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Drug Liberation |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D000818 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Animals |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D000077182 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Polylactic Acid-Polyglycolic Acid Copolymer |
| mesh[20].qualifier_ui | Q000188 |
| mesh[20].descriptor_ui | D005901 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | drug therapy |
| mesh[20].descriptor_name | Glaucoma |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D008863 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Microspheres |
| mesh[22].qualifier_ui | Q000008 |
| mesh[22].descriptor_ui | D018696 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | administration & dosage |
| mesh[22].descriptor_name | Neuroprotective Agents |
| mesh[23].qualifier_ui | Q000737 |
| mesh[23].descriptor_ui | D018696 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | chemistry |
| mesh[23].descriptor_name | Neuroprotective Agents |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D004195 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Disease Models, Animal |
| mesh[25].qualifier_ui | Q000008 |
| mesh[25].descriptor_ui | D003907 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | administration & dosage |
| mesh[25].descriptor_name | Dexamethasone |
| mesh[26].qualifier_ui | Q000737 |
| mesh[26].descriptor_ui | D003907 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | chemistry |
| mesh[26].descriptor_name | Dexamethasone |
| mesh[27].qualifier_ui | Q000737 |
| mesh[27].descriptor_ui | D011100 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | chemistry |
| mesh[27].descriptor_name | Polyglycolic Acid |
| mesh[28].qualifier_ui | Q000008 |
| mesh[28].descriptor_ui | D011100 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | administration & dosage |
| mesh[28].descriptor_name | Polyglycolic Acid |
| mesh[29].qualifier_ui | Q000737 |
| mesh[29].descriptor_ui | D019344 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | chemistry |
| mesh[29].descriptor_name | Lactic Acid |
| mesh[30].qualifier_ui | Q000008 |
| mesh[30].descriptor_ui | D019344 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | administration & dosage |
| mesh[30].descriptor_name | Lactic Acid |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D051381 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Rats |
| mesh[32].qualifier_ui | Q000008 |
| mesh[32].descriptor_ui | D051100 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | administration & dosage |
| mesh[32].descriptor_name | Glial Cell Line-Derived Neurotrophic Factor |
| mesh[33].qualifier_ui | Q000737 |
| mesh[33].descriptor_ui | D051100 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | chemistry |
| mesh[33].descriptor_name | Glial Cell Line-Derived Neurotrophic Factor |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D008297 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Male |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D065546 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Drug Liberation |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D000818 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Animals |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D000077182 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Polylactic Acid-Polyglycolic Acid Copolymer |
| mesh[38].qualifier_ui | Q000188 |
| mesh[38].descriptor_ui | D005901 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | drug therapy |
| mesh[38].descriptor_name | Glaucoma |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D008863 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Microspheres |
| mesh[40].qualifier_ui | Q000008 |
| mesh[40].descriptor_ui | D018696 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | administration & dosage |
| mesh[40].descriptor_name | Neuroprotective Agents |
| mesh[41].qualifier_ui | Q000737 |
| mesh[41].descriptor_ui | D018696 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | chemistry |
| mesh[41].descriptor_name | Neuroprotective Agents |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D004195 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Disease Models, Animal |
| mesh[43].qualifier_ui | Q000008 |
| mesh[43].descriptor_ui | D003907 |
| mesh[43].is_major_topic | True |
| mesh[43].qualifier_name | administration & dosage |
| mesh[43].descriptor_name | Dexamethasone |
| mesh[44].qualifier_ui | Q000737 |
| mesh[44].descriptor_ui | D003907 |
| mesh[44].is_major_topic | True |
| mesh[44].qualifier_name | chemistry |
| mesh[44].descriptor_name | Dexamethasone |
| mesh[45].qualifier_ui | Q000737 |
| mesh[45].descriptor_ui | D011100 |
| mesh[45].is_major_topic | True |
| mesh[45].qualifier_name | chemistry |
| mesh[45].descriptor_name | Polyglycolic Acid |
| mesh[46].qualifier_ui | Q000008 |
| mesh[46].descriptor_ui | D011100 |
| mesh[46].is_major_topic | True |
| mesh[46].qualifier_name | administration & dosage |
| mesh[46].descriptor_name | Polyglycolic Acid |
| mesh[47].qualifier_ui | Q000737 |
| mesh[47].descriptor_ui | D019344 |
| mesh[47].is_major_topic | True |
| mesh[47].qualifier_name | chemistry |
| mesh[47].descriptor_name | Lactic Acid |
| mesh[48].qualifier_ui | Q000008 |
| mesh[48].descriptor_ui | D019344 |
| mesh[48].is_major_topic | True |
| mesh[48].qualifier_name | administration & dosage |
| mesh[48].descriptor_name | Lactic Acid |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D051381 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Rats |
| type | article |
| title | Multi-loaded PLGA microspheres as neuroretinal therapy in a chronic glaucoma animal model |
| biblio.issue | 5 |
| biblio.volume | 15 |
| biblio.last_page | 1684 |
| biblio.first_page | 1660 |
| grants[0].funder | https://openalex.org/F4320321585 |
| grants[0].award_id | UCM-Santander fellowship (CT17/17-CT17-18). |
| grants[0].funder_display_name | Universidad Complutense de Madrid |
| grants[1].funder | https://openalex.org/F4320322930 |
| grants[1].award_id | MAT2017-83858-C2-1 |
| grants[1].funder_display_name | Ministerio de Ciencia e Innovación |
| grants[2].funder | https://openalex.org/F4320322930 |
| grants[2].award_id | MAT2017-83858-C2-2 |
| grants[2].funder_display_name | Ministerio de Ciencia e Innovación |
| grants[3].funder | https://openalex.org/F4320322930 |
| grants[3].award_id | PID2020-113281RB-C21 |
| grants[3].funder_display_name | Ministerio de Ciencia e Innovación |
| grants[4].funder | https://openalex.org/F4320322930 |
| grants[4].award_id | PID2020-113281RB-C22 |
| grants[4].funder_display_name | Ministerio de Ciencia e Innovación |
| grants[5].funder | https://openalex.org/F4320322930 |
| grants[5].award_id | PRE2018-083951 |
| grants[5].funder_display_name | Ministerio de Ciencia e Innovación |
| topics[0].id | https://openalex.org/T10250 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2731 |
| topics[0].subfield.display_name | Ophthalmology |
| topics[0].display_name | Glaucoma and retinal disorders |
| topics[1].id | https://openalex.org/T10997 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9993000030517578 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2739 |
| topics[1].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[1].display_name | Ocular Surface and Contact Lens |
| topics[2].id | https://openalex.org/T12484 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9965999722480774 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2741 |
| topics[2].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[2].display_name | Retinopathy of Prematurity Studies |
| funders[0].id | https://openalex.org/F4320321585 |
| funders[0].ror | https://ror.org/02p0gd045 |
| funders[0].display_name | Universidad Complutense de Madrid |
| funders[1].id | https://openalex.org/F4320322930 |
| funders[1].ror | https://ror.org/034900433 |
| funders[1].display_name | Ministerio de Ciencia e Innovación |
| is_xpac | False |
| apc_list.value | 3390 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4190 |
| apc_paid.value | 3390 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 4190 |
| concepts[0].id | https://openalex.org/C2780165375 |
| concepts[0].level | 3 |
| concepts[0].score | 0.5972450375556946 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q2102907 |
| concepts[0].display_name | PLGA |
| concepts[1].id | https://openalex.org/C185856081 |
| concepts[1].level | 4 |
| concepts[1].score | 0.588145911693573 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q14916286 |
| concepts[1].display_name | Glial cell line-derived neurotrophic factor |
| concepts[2].id | https://openalex.org/C2778527774 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5817936658859253 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q159701 |
| concepts[2].display_name | Glaucoma |
| concepts[3].id | https://openalex.org/C207001950 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5712030529975891 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q141124 |
| concepts[3].display_name | In vivo |
| concepts[4].id | https://openalex.org/C25498285 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5611805319786072 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1981368 |
| concepts[4].display_name | Neuroprotection |
| concepts[5].id | https://openalex.org/C2780401358 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5249897241592407 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q422252 |
| concepts[5].display_name | Dexamethasone |
| concepts[6].id | https://openalex.org/C2780472526 |
| concepts[6].level | 4 |
| concepts[6].score | 0.5151857137680054 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q409373 |
| concepts[6].display_name | Glycolic acid |
| concepts[7].id | https://openalex.org/C101335993 |
| concepts[7].level | 4 |
| concepts[7].score | 0.5116375088691711 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q408943 |
| concepts[7].display_name | Poloxamer |
| concepts[8].id | https://openalex.org/C2779742858 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4715706706047058 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q180609 |
| concepts[8].display_name | Intravitreal administration |
| concepts[9].id | https://openalex.org/C185592680 |
| concepts[9].level | 0 |
| concepts[9].score | 0.44304123520851135 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[9].display_name | Chemistry |
| concepts[10].id | https://openalex.org/C136229726 |
| concepts[10].level | 1 |
| concepts[10].score | 0.42922890186309814 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q327092 |
| concepts[10].display_name | Biomedical engineering |
| concepts[11].id | https://openalex.org/C160539049 |
| concepts[11].level | 3 |
| concepts[11].score | 0.4041443169116974 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q3064187 |
| concepts[11].display_name | Neurotrophic factors |
| concepts[12].id | https://openalex.org/C98274493 |
| concepts[12].level | 1 |
| concepts[12].score | 0.38408541679382324 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[12].display_name | Pharmacology |
| concepts[13].id | https://openalex.org/C43617362 |
| concepts[13].level | 1 |
| concepts[13].score | 0.37213587760925293 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q170050 |
| concepts[13].display_name | Chromatography |
| concepts[14].id | https://openalex.org/C192562407 |
| concepts[14].level | 0 |
| concepts[14].score | 0.32016563415527344 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q228736 |
| concepts[14].display_name | Materials science |
| concepts[15].id | https://openalex.org/C71924100 |
| concepts[15].level | 0 |
| concepts[15].score | 0.2543136477470398 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[15].display_name | Medicine |
| concepts[16].id | https://openalex.org/C118487528 |
| concepts[16].level | 1 |
| concepts[16].score | 0.24765610694885254 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q161437 |
| concepts[16].display_name | Ophthalmology |
| concepts[17].id | https://openalex.org/C2775920511 |
| concepts[17].level | 3 |
| concepts[17].score | 0.22924795746803284 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q161249 |
| concepts[17].display_name | Lactic acid |
| concepts[18].id | https://openalex.org/C2780827179 |
| concepts[18].level | 2 |
| concepts[18].score | 0.2127850353717804 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q422001 |
| concepts[18].display_name | Retinal |
| concepts[19].id | https://openalex.org/C55493867 |
| concepts[19].level | 1 |
| concepts[19].score | 0.16417694091796875 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[19].display_name | Biochemistry |
| concepts[20].id | https://openalex.org/C202751555 |
| concepts[20].level | 2 |
| concepts[20].score | 0.154793381690979 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[20].display_name | In vitro |
| concepts[21].id | https://openalex.org/C178790620 |
| concepts[21].level | 1 |
| concepts[21].score | 0.10199812054634094 |
| concepts[21].wikidata | https://www.wikidata.org/wiki/Q11351 |
| concepts[21].display_name | Organic chemistry |
| concepts[22].id | https://openalex.org/C15920480 |
| concepts[22].level | 3 |
| concepts[22].score | 0.10162532329559326 |
| concepts[22].wikidata | https://www.wikidata.org/wiki/Q421281 |
| concepts[22].display_name | Copolymer |
| concepts[23].id | https://openalex.org/C54355233 |
| concepts[23].level | 1 |
| concepts[23].score | 0.0 |
| concepts[23].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[23].display_name | Genetics |
| concepts[24].id | https://openalex.org/C134018914 |
| concepts[24].level | 1 |
| concepts[24].score | 0.0 |
| concepts[24].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[24].display_name | Endocrinology |
| concepts[25].id | https://openalex.org/C86803240 |
| concepts[25].level | 0 |
| concepts[25].score | 0.0 |
| concepts[25].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[25].display_name | Biology |
| concepts[26].id | https://openalex.org/C170493617 |
| concepts[26].level | 2 |
| concepts[26].score | 0.0 |
| concepts[26].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[26].display_name | Receptor |
| concepts[27].id | https://openalex.org/C150903083 |
| concepts[27].level | 1 |
| concepts[27].score | 0.0 |
| concepts[27].wikidata | https://www.wikidata.org/wiki/Q7108 |
| concepts[27].display_name | Biotechnology |
| concepts[28].id | https://openalex.org/C523546767 |
| concepts[28].level | 2 |
| concepts[28].score | 0.0 |
| concepts[28].wikidata | https://www.wikidata.org/wiki/Q10876 |
| concepts[28].display_name | Bacteria |
| concepts[29].id | https://openalex.org/C521977710 |
| concepts[29].level | 2 |
| concepts[29].score | 0.0 |
| concepts[29].wikidata | https://www.wikidata.org/wiki/Q81163 |
| concepts[29].display_name | Polymer |
| keywords[0].id | https://openalex.org/keywords/plga |
| keywords[0].score | 0.5972450375556946 |
| keywords[0].display_name | PLGA |
| keywords[1].id | https://openalex.org/keywords/glial-cell-line-derived-neurotrophic-factor |
| keywords[1].score | 0.588145911693573 |
| keywords[1].display_name | Glial cell line-derived neurotrophic factor |
| keywords[2].id | https://openalex.org/keywords/glaucoma |
| keywords[2].score | 0.5817936658859253 |
| keywords[2].display_name | Glaucoma |
| keywords[3].id | https://openalex.org/keywords/in-vivo |
| keywords[3].score | 0.5712030529975891 |
| keywords[3].display_name | In vivo |
| keywords[4].id | https://openalex.org/keywords/neuroprotection |
| keywords[4].score | 0.5611805319786072 |
| keywords[4].display_name | Neuroprotection |
| keywords[5].id | https://openalex.org/keywords/dexamethasone |
| keywords[5].score | 0.5249897241592407 |
| keywords[5].display_name | Dexamethasone |
| keywords[6].id | https://openalex.org/keywords/glycolic-acid |
| keywords[6].score | 0.5151857137680054 |
| keywords[6].display_name | Glycolic acid |
| keywords[7].id | https://openalex.org/keywords/poloxamer |
| keywords[7].score | 0.5116375088691711 |
| keywords[7].display_name | Poloxamer |
| keywords[8].id | https://openalex.org/keywords/intravitreal-administration |
| keywords[8].score | 0.4715706706047058 |
| keywords[8].display_name | Intravitreal administration |
| keywords[9].id | https://openalex.org/keywords/chemistry |
| keywords[9].score | 0.44304123520851135 |
| keywords[9].display_name | Chemistry |
| keywords[10].id | https://openalex.org/keywords/biomedical-engineering |
| keywords[10].score | 0.42922890186309814 |
| keywords[10].display_name | Biomedical engineering |
| keywords[11].id | https://openalex.org/keywords/neurotrophic-factors |
| keywords[11].score | 0.4041443169116974 |
| keywords[11].display_name | Neurotrophic factors |
| keywords[12].id | https://openalex.org/keywords/pharmacology |
| keywords[12].score | 0.38408541679382324 |
| keywords[12].display_name | Pharmacology |
| keywords[13].id | https://openalex.org/keywords/chromatography |
| keywords[13].score | 0.37213587760925293 |
| keywords[13].display_name | Chromatography |
| keywords[14].id | https://openalex.org/keywords/materials-science |
| keywords[14].score | 0.32016563415527344 |
| keywords[14].display_name | Materials science |
| keywords[15].id | https://openalex.org/keywords/medicine |
| keywords[15].score | 0.2543136477470398 |
| keywords[15].display_name | Medicine |
| keywords[16].id | https://openalex.org/keywords/ophthalmology |
| keywords[16].score | 0.24765610694885254 |
| keywords[16].display_name | Ophthalmology |
| keywords[17].id | https://openalex.org/keywords/lactic-acid |
| keywords[17].score | 0.22924795746803284 |
| keywords[17].display_name | Lactic acid |
| keywords[18].id | https://openalex.org/keywords/retinal |
| keywords[18].score | 0.2127850353717804 |
| keywords[18].display_name | Retinal |
| keywords[19].id | https://openalex.org/keywords/biochemistry |
| keywords[19].score | 0.16417694091796875 |
| keywords[19].display_name | Biochemistry |
| keywords[20].id | https://openalex.org/keywords/in-vitro |
| keywords[20].score | 0.154793381690979 |
| keywords[20].display_name | In vitro |
| keywords[21].id | https://openalex.org/keywords/organic-chemistry |
| keywords[21].score | 0.10199812054634094 |
| keywords[21].display_name | Organic chemistry |
| keywords[22].id | https://openalex.org/keywords/copolymer |
| keywords[22].score | 0.10162532329559326 |
| keywords[22].display_name | Copolymer |
| language | en |
| locations[0].id | doi:10.1007/s13346-024-01702-x |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2764352022 |
| locations[0].source.issn | 2190-393X, 2190-3948 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2190-393X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Drug Delivery and Translational Research |
| locations[0].source.host_organization | https://openalex.org/P4310319900 |
| locations[0].source.host_organization_name | Springer Science+Business Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319900 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Drug Delivery and Translational Research |
| locations[0].landing_page_url | https://doi.org/10.1007/s13346-024-01702-x |
| locations[1].id | pmh:oai:zaguan.unizar.es:150530 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306401812 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | Zaguan (University of Zaragoza Repository) |
| locations[1].source.host_organization | https://openalex.org/I255234318 |
| locations[1].source.host_organization_name | Universidad de Zaragoza |
| locations[1].source.host_organization_lineage | https://openalex.org/I255234318 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | info:eu-repo/semantics/publishedVersion |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | http://zaguan.unizar.es/record/150530 |
| locations[2].id | pmid:39361228 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306525036 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | publishedVersion |
| locations[2].raw_type | |
| locations[2].license_id | |
| locations[2].is_accepted | True |
| locations[2].is_published | True |
| locations[2].raw_source_name | Drug delivery and translational research |
| locations[2].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39361228 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:11968513 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Drug Deliv Transl Res |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11968513 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5017381888 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-7466-8914 |
| authorships[0].author.display_name | Alba Aragón-Navas |
| authorships[0].countries | ES |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210097846 |
| authorships[0].affiliations[0].raw_affiliation_string | Health Research Institute, San Carlos Clinical Hospital (IdISSC), Madrid, Spain. |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I121748325 |
| authorships[0].affiliations[1].raw_affiliation_string | Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain. |
| authorships[0].institutions[0].id | https://openalex.org/I4210097846 |
| authorships[0].institutions[0].ror | https://ror.org/014v12a39 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210097846 |
| authorships[0].institutions[0].country_code | ES |
| authorships[0].institutions[0].display_name | Instituto de Investigación Sanitaria del Hospital Clínico San Carlos |
| authorships[0].institutions[1].id | https://openalex.org/I121748325 |
| authorships[0].institutions[1].ror | https://ror.org/02p0gd045 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I121748325 |
| authorships[0].institutions[1].country_code | ES |
| authorships[0].institutions[1].display_name | Universidad Complutense de Madrid |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Alba Aragón-Navas |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Health Research Institute, San Carlos Clinical Hospital (IdISSC), Madrid, Spain., Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain. |
| authorships[1].author.id | https://openalex.org/A5069261832 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-4009-3075 |
| authorships[1].author.display_name | María Jesús Rodrigo |
| authorships[1].countries | ES |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2801357902 |
| authorships[1].affiliations[0].raw_affiliation_string | National Ocular Research Network RD21/0002/0050. RICORS Red de Enfermedades Inflamatorias (RD21/0002), Carlos III Health Institute, Madrid, Spain. |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I4210114530 |
| authorships[1].affiliations[1].raw_affiliation_string | Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain. |
| authorships[1].affiliations[2].institution_ids | https://openalex.org/I255234318, https://openalex.org/I4210136512 |
| authorships[1].affiliations[2].raw_affiliation_string | Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, Zaragoza, Spain. |
| authorships[1].institutions[0].id | https://openalex.org/I4210114530 |
| authorships[1].institutions[0].ror | https://ror.org/01r13mt55 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210114530 |
| authorships[1].institutions[0].country_code | ES |
| authorships[1].institutions[0].display_name | Hospital Universitario Miguel Servet |
| authorships[1].institutions[1].id | https://openalex.org/I4210136512 |
| authorships[1].institutions[1].ror | https://ror.org/03njn4610 |
| authorships[1].institutions[1].type | other |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210136512 |
| authorships[1].institutions[1].country_code | ES |
| authorships[1].institutions[1].display_name | Instituto de Investigación Sanitaria Aragón |
| authorships[1].institutions[2].id | https://openalex.org/I2801357902 |
| authorships[1].institutions[2].ror | https://ror.org/00ca2c886 |
| authorships[1].institutions[2].type | nonprofit |
| authorships[1].institutions[2].lineage | https://openalex.org/I2801357902, https://openalex.org/I4387152914 |
| authorships[1].institutions[2].country_code | ES |
| authorships[1].institutions[2].display_name | Instituto de Salud Carlos III |
| authorships[1].institutions[3].id | https://openalex.org/I255234318 |
| authorships[1].institutions[3].ror | https://ror.org/012a91z28 |
| authorships[1].institutions[3].type | education |
| authorships[1].institutions[3].lineage | https://openalex.org/I255234318 |
| authorships[1].institutions[3].country_code | ES |
| authorships[1].institutions[3].display_name | Universidad de Zaragoza |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Maria Jesus Rodrigo |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain., Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, Zaragoza, Spain., National Ocular Research Network RD21/0002/0050. RICORS Red de Enfermedades Inflamatorias (RD21/0002), Carlos III Health Institute, Madrid, Spain. |
| authorships[2].author.id | https://openalex.org/A5091905586 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-1502-641X |
| authorships[2].author.display_name | Inés Munuera |
| authorships[2].countries | ES |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I255234318, https://openalex.org/I4210136512 |
| authorships[2].affiliations[0].raw_affiliation_string | Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, Zaragoza, Spain. |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I4210114530 |
| authorships[2].affiliations[1].raw_affiliation_string | Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain. |
| authorships[2].institutions[0].id | https://openalex.org/I4210114530 |
| authorships[2].institutions[0].ror | https://ror.org/01r13mt55 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210114530 |
| authorships[2].institutions[0].country_code | ES |
| authorships[2].institutions[0].display_name | Hospital Universitario Miguel Servet |
| authorships[2].institutions[1].id | https://openalex.org/I4210136512 |
| authorships[2].institutions[1].ror | https://ror.org/03njn4610 |
| authorships[2].institutions[1].type | other |
| authorships[2].institutions[1].lineage | https://openalex.org/I4210136512 |
| authorships[2].institutions[1].country_code | ES |
| authorships[2].institutions[1].display_name | Instituto de Investigación Sanitaria Aragón |
| authorships[2].institutions[2].id | https://openalex.org/I255234318 |
| authorships[2].institutions[2].ror | https://ror.org/012a91z28 |
| authorships[2].institutions[2].type | education |
| authorships[2].institutions[2].lineage | https://openalex.org/I255234318 |
| authorships[2].institutions[2].country_code | ES |
| authorships[2].institutions[2].display_name | Universidad de Zaragoza |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Inés Munuera |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain., Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, Zaragoza, Spain. |
| authorships[3].author.id | https://openalex.org/A5044504479 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-2092-5927 |
| authorships[3].author.display_name | David García-Herranz |
| authorships[3].countries | ES |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210097846 |
| authorships[3].affiliations[0].raw_affiliation_string | Health Research Institute, San Carlos Clinical Hospital (IdISSC), Madrid, Spain. |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I121748325 |
| authorships[3].affiliations[1].raw_affiliation_string | Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain. |
| authorships[3].institutions[0].id | https://openalex.org/I4210097846 |
| authorships[3].institutions[0].ror | https://ror.org/014v12a39 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210097846 |
| authorships[3].institutions[0].country_code | ES |
| authorships[3].institutions[0].display_name | Instituto de Investigación Sanitaria del Hospital Clínico San Carlos |
| authorships[3].institutions[1].id | https://openalex.org/I121748325 |
| authorships[3].institutions[1].ror | https://ror.org/02p0gd045 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I121748325 |
| authorships[3].institutions[1].country_code | ES |
| authorships[3].institutions[1].display_name | Universidad Complutense de Madrid |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | David García-Herranz |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Health Research Institute, San Carlos Clinical Hospital (IdISSC), Madrid, Spain., Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain. |
| authorships[4].author.id | https://openalex.org/A5019494571 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-2344-016X |
| authorships[4].author.display_name | Manuel Subías |
| authorships[4].countries | ES |
| authorships[4].affiliations[0].raw_affiliation_string | Biotech Vision, Instituto Oftalmologico Quiron, Zaragoza, Spain. |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I255234318, https://openalex.org/I4210136512 |
| authorships[4].affiliations[1].raw_affiliation_string | Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, Zaragoza, Spain. |
| authorships[4].affiliations[2].institution_ids | https://openalex.org/I4210114530 |
| authorships[4].affiliations[2].raw_affiliation_string | Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain. |
| authorships[4].institutions[0].id | https://openalex.org/I4210114530 |
| authorships[4].institutions[0].ror | https://ror.org/01r13mt55 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210114530 |
| authorships[4].institutions[0].country_code | ES |
| authorships[4].institutions[0].display_name | Hospital Universitario Miguel Servet |
| authorships[4].institutions[1].id | https://openalex.org/I4210136512 |
| authorships[4].institutions[1].ror | https://ror.org/03njn4610 |
| authorships[4].institutions[1].type | other |
| authorships[4].institutions[1].lineage | https://openalex.org/I4210136512 |
| authorships[4].institutions[1].country_code | ES |
| authorships[4].institutions[1].display_name | Instituto de Investigación Sanitaria Aragón |
| authorships[4].institutions[2].id | https://openalex.org/I255234318 |
| authorships[4].institutions[2].ror | https://ror.org/012a91z28 |
| authorships[4].institutions[2].type | education |
| authorships[4].institutions[2].lineage | https://openalex.org/I255234318 |
| authorships[4].institutions[2].country_code | ES |
| authorships[4].institutions[2].display_name | Universidad de Zaragoza |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Manuel Subías |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Biotech Vision, Instituto Oftalmologico Quiron, Zaragoza, Spain., Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain., Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, Zaragoza, Spain. |
| authorships[5].author.id | https://openalex.org/A5070699149 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-2860-7475 |
| authorships[5].author.display_name | Pilar Villacampa |
| authorships[5].countries | ES |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2802050225, https://openalex.org/I4210087039, https://openalex.org/I71999127 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Physiological Sciences, Faculty of Medicine and Health Sciences, University of Barcelona and Bellvitge Biomedical Research Institute (IDIBELL), Feixa Llarga S/N, 08907, L'Hospitalet de Llobregat, Spain. |
| authorships[5].institutions[0].id | https://openalex.org/I2802050225 |
| authorships[5].institutions[0].ror | https://ror.org/00epner96 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210153292 |
| authorships[5].institutions[0].country_code | ES |
| authorships[5].institutions[0].display_name | Bellvitge University Hospital |
| authorships[5].institutions[1].id | https://openalex.org/I4210087039 |
| authorships[5].institutions[1].ror | https://ror.org/0008xqs48 |
| authorships[5].institutions[1].type | facility |
| authorships[5].institutions[1].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210087039, https://openalex.org/I4210096656, https://openalex.org/I4210106543, https://openalex.org/I4210107147, https://openalex.org/I4210153292, https://openalex.org/I4387153040, https://openalex.org/I71999127 |
| authorships[5].institutions[1].country_code | ES |
| authorships[5].institutions[1].display_name | Institut d'Investigació Biomédica de Bellvitge |
| authorships[5].institutions[2].id | https://openalex.org/I71999127 |
| authorships[5].institutions[2].ror | https://ror.org/021018s57 |
| authorships[5].institutions[2].type | education |
| authorships[5].institutions[2].lineage | https://openalex.org/I71999127 |
| authorships[5].institutions[2].country_code | ES |
| authorships[5].institutions[2].display_name | Universitat de Barcelona |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Pilar Villacampa |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Physiological Sciences, Faculty of Medicine and Health Sciences, University of Barcelona and Bellvitge Biomedical Research Institute (IDIBELL), Feixa Llarga S/N, 08907, L'Hospitalet de Llobregat, Spain. |
| authorships[6].author.id | https://openalex.org/A5067804224 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-7772-5718 |
| authorships[6].author.display_name | J. García–Sánchez |
| authorships[6].countries | ES |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210097846 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Ophthalmology, San Carlos Clinical Hospital, Health Research Institute of the San Carlos Clinical Hospital (IdISSC), Madrid, Spain. |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I121748325 |
| authorships[6].affiliations[1].raw_affiliation_string | University Institute for Industrial Pharmacy (IUFI), School of Pharmacy, Complutense University of Madrid, Madrid, Spain. |
| authorships[6].institutions[0].id | https://openalex.org/I4210097846 |
| authorships[6].institutions[0].ror | https://ror.org/014v12a39 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210097846 |
| authorships[6].institutions[0].country_code | ES |
| authorships[6].institutions[0].display_name | Instituto de Investigación Sanitaria del Hospital Clínico San Carlos |
| authorships[6].institutions[1].id | https://openalex.org/I121748325 |
| authorships[6].institutions[1].ror | https://ror.org/02p0gd045 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I121748325 |
| authorships[6].institutions[1].country_code | ES |
| authorships[6].institutions[1].display_name | Universidad Complutense de Madrid |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Julián García-Feijoo |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Ophthalmology, San Carlos Clinical Hospital, Health Research Institute of the San Carlos Clinical Hospital (IdISSC), Madrid, Spain., University Institute for Industrial Pharmacy (IUFI), School of Pharmacy, Complutense University of Madrid, Madrid, Spain. |
| authorships[7].author.id | https://openalex.org/A5089248502 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2389-8282 |
| authorships[7].author.display_name | Luís E. Pablo |
| authorships[7].countries | ES |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I255234318, https://openalex.org/I4210136512 |
| authorships[7].affiliations[0].raw_affiliation_string | Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, Zaragoza, Spain. |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I2801357902 |
| authorships[7].affiliations[1].raw_affiliation_string | National Ocular Research Network RD21/0002/0050. RICORS Red de Enfermedades Inflamatorias (RD21/0002), Carlos III Health Institute, Madrid, Spain. |
| authorships[7].affiliations[2].institution_ids | https://openalex.org/I4210114530 |
| authorships[7].affiliations[2].raw_affiliation_string | Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain. |
| authorships[7].affiliations[3].raw_affiliation_string | Biotech Vision, Instituto Oftalmologico Quiron, Zaragoza, Spain. |
| authorships[7].institutions[0].id | https://openalex.org/I4210114530 |
| authorships[7].institutions[0].ror | https://ror.org/01r13mt55 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210114530 |
| authorships[7].institutions[0].country_code | ES |
| authorships[7].institutions[0].display_name | Hospital Universitario Miguel Servet |
| authorships[7].institutions[1].id | https://openalex.org/I4210136512 |
| authorships[7].institutions[1].ror | https://ror.org/03njn4610 |
| authorships[7].institutions[1].type | other |
| authorships[7].institutions[1].lineage | https://openalex.org/I4210136512 |
| authorships[7].institutions[1].country_code | ES |
| authorships[7].institutions[1].display_name | Instituto de Investigación Sanitaria Aragón |
| authorships[7].institutions[2].id | https://openalex.org/I2801357902 |
| authorships[7].institutions[2].ror | https://ror.org/00ca2c886 |
| authorships[7].institutions[2].type | nonprofit |
| authorships[7].institutions[2].lineage | https://openalex.org/I2801357902, https://openalex.org/I4387152914 |
| authorships[7].institutions[2].country_code | ES |
| authorships[7].institutions[2].display_name | Instituto de Salud Carlos III |
| authorships[7].institutions[3].id | https://openalex.org/I255234318 |
| authorships[7].institutions[3].ror | https://ror.org/012a91z28 |
| authorships[7].institutions[3].type | education |
| authorships[7].institutions[3].lineage | https://openalex.org/I255234318 |
| authorships[7].institutions[3].country_code | ES |
| authorships[7].institutions[3].display_name | Universidad de Zaragoza |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Luis Pablo |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Biotech Vision, Instituto Oftalmologico Quiron, Zaragoza, Spain., Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain., Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, Zaragoza, Spain., National Ocular Research Network RD21/0002/0050. RICORS Red de Enfermedades Inflamatorias (RD21/0002), Carlos III Health Institute, Madrid, Spain. |
| authorships[8].author.id | https://openalex.org/A5015094639 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-6258-2489 |
| authorships[8].author.display_name | Elena García‐Martín |
| authorships[8].countries | ES |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I2801357902 |
| authorships[8].affiliations[0].raw_affiliation_string | National Ocular Research Network RD21/0002/0050. RICORS Red de Enfermedades Inflamatorias (RD21/0002), Carlos III Health Institute, Madrid, Spain. |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I255234318, https://openalex.org/I4210136512 |
| authorships[8].affiliations[1].raw_affiliation_string | Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, Zaragoza, Spain. |
| authorships[8].affiliations[2].institution_ids | https://openalex.org/I4210114530 |
| authorships[8].affiliations[2].raw_affiliation_string | Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain. |
| authorships[8].institutions[0].id | https://openalex.org/I4210114530 |
| authorships[8].institutions[0].ror | https://ror.org/01r13mt55 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210114530 |
| authorships[8].institutions[0].country_code | ES |
| authorships[8].institutions[0].display_name | Hospital Universitario Miguel Servet |
| authorships[8].institutions[1].id | https://openalex.org/I4210136512 |
| authorships[8].institutions[1].ror | https://ror.org/03njn4610 |
| authorships[8].institutions[1].type | other |
| authorships[8].institutions[1].lineage | https://openalex.org/I4210136512 |
| authorships[8].institutions[1].country_code | ES |
| authorships[8].institutions[1].display_name | Instituto de Investigación Sanitaria Aragón |
| authorships[8].institutions[2].id | https://openalex.org/I2801357902 |
| authorships[8].institutions[2].ror | https://ror.org/00ca2c886 |
| authorships[8].institutions[2].type | nonprofit |
| authorships[8].institutions[2].lineage | https://openalex.org/I2801357902, https://openalex.org/I4387152914 |
| authorships[8].institutions[2].country_code | ES |
| authorships[8].institutions[2].display_name | Instituto de Salud Carlos III |
| authorships[8].institutions[3].id | https://openalex.org/I255234318 |
| authorships[8].institutions[3].ror | https://ror.org/012a91z28 |
| authorships[8].institutions[3].type | education |
| authorships[8].institutions[3].lineage | https://openalex.org/I255234318 |
| authorships[8].institutions[3].country_code | ES |
| authorships[8].institutions[3].display_name | Universidad de Zaragoza |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Elena Garcia-Martin |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain., Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, Zaragoza, Spain., National Ocular Research Network RD21/0002/0050. RICORS Red de Enfermedades Inflamatorias (RD21/0002), Carlos III Health Institute, Madrid, Spain. |
| authorships[9].author.id | https://openalex.org/A5073742899 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-9764-7975 |
| authorships[9].author.display_name | Rocío Herrero‐Vanrell |
| authorships[9].countries | ES |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210097846 |
| authorships[9].affiliations[0].raw_affiliation_string | Health Research Institute, San Carlos Clinical Hospital (IdISSC), Madrid, Spain. |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I2801357902 |
| authorships[9].affiliations[1].raw_affiliation_string | National Ocular Pathology Network (OFTARED), Carlos III Health Institute, Madrid, Spain. |
| authorships[9].affiliations[2].institution_ids | https://openalex.org/I121748325 |
| authorships[9].affiliations[2].raw_affiliation_string | Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain. |
| authorships[9].institutions[0].id | https://openalex.org/I4210097846 |
| authorships[9].institutions[0].ror | https://ror.org/014v12a39 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210097846 |
| authorships[9].institutions[0].country_code | ES |
| authorships[9].institutions[0].display_name | Instituto de Investigación Sanitaria del Hospital Clínico San Carlos |
| authorships[9].institutions[1].id | https://openalex.org/I2801357902 |
| authorships[9].institutions[1].ror | https://ror.org/00ca2c886 |
| authorships[9].institutions[1].type | nonprofit |
| authorships[9].institutions[1].lineage | https://openalex.org/I2801357902, https://openalex.org/I4387152914 |
| authorships[9].institutions[1].country_code | ES |
| authorships[9].institutions[1].display_name | Instituto de Salud Carlos III |
| authorships[9].institutions[2].id | https://openalex.org/I121748325 |
| authorships[9].institutions[2].ror | https://ror.org/02p0gd045 |
| authorships[9].institutions[2].type | education |
| authorships[9].institutions[2].lineage | https://openalex.org/I121748325 |
| authorships[9].institutions[2].country_code | ES |
| authorships[9].institutions[2].display_name | Universidad Complutense de Madrid |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Rocio Herrero-Vanrell |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Health Research Institute, San Carlos Clinical Hospital (IdISSC), Madrid, Spain., Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain., National Ocular Pathology Network (OFTARED), Carlos III Health Institute, Madrid, Spain. |
| authorships[10].author.id | https://openalex.org/A5067450361 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-3133-7872 |
| authorships[10].author.display_name | Irene Bravo‐Osuna |
| authorships[10].countries | ES |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I121748325 |
| authorships[10].affiliations[0].raw_affiliation_string | University Institute for Industrial Pharmacy (IUFI), School of Pharmacy, Complutense University of Madrid, Madrid, Spain. [email protected]. |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I2801357902 |
| authorships[10].affiliations[1].raw_affiliation_string | National Ocular Pathology Network (OFTARED), Carlos III Health Institute, Madrid, Spain. [email protected]. |
| authorships[10].affiliations[2].institution_ids | https://openalex.org/I4210097846 |
| authorships[10].affiliations[2].raw_affiliation_string | Health Research Institute, San Carlos Clinical Hospital (IdISSC), Madrid, Spain. [email protected]. |
| authorships[10].affiliations[3].institution_ids | https://openalex.org/I121748325 |
| authorships[10].affiliations[3].raw_affiliation_string | Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain. [email protected]. |
| authorships[10].institutions[0].id | https://openalex.org/I4210097846 |
| authorships[10].institutions[0].ror | https://ror.org/014v12a39 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210097846 |
| authorships[10].institutions[0].country_code | ES |
| authorships[10].institutions[0].display_name | Instituto de Investigación Sanitaria del Hospital Clínico San Carlos |
| authorships[10].institutions[1].id | https://openalex.org/I2801357902 |
| authorships[10].institutions[1].ror | https://ror.org/00ca2c886 |
| authorships[10].institutions[1].type | nonprofit |
| authorships[10].institutions[1].lineage | https://openalex.org/I2801357902, https://openalex.org/I4387152914 |
| authorships[10].institutions[1].country_code | ES |
| authorships[10].institutions[1].display_name | Instituto de Salud Carlos III |
| authorships[10].institutions[2].id | https://openalex.org/I121748325 |
| authorships[10].institutions[2].ror | https://ror.org/02p0gd045 |
| authorships[10].institutions[2].type | education |
| authorships[10].institutions[2].lineage | https://openalex.org/I121748325 |
| authorships[10].institutions[2].country_code | ES |
| authorships[10].institutions[2].display_name | Universidad Complutense de Madrid |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Irene Bravo-Osuna |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Health Research Institute, San Carlos Clinical Hospital (IdISSC), Madrid, Spain. [email protected]., Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain. [email protected]., National Ocular Pathology Network (OFTARED), Carlos III Health Institute, Madrid, Spain. [email protected]., University Institute for Industrial Pharmacy (IUFI), School of Pharmacy, Complutense University of Madrid, Madrid, Spain. [email protected]. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1007/s13346-024-01702-x |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Multi-loaded PLGA microspheres as neuroretinal therapy in a chronic glaucoma animal model |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-20T23:13:51.555489 |
| primary_topic.id | https://openalex.org/T10250 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2731 |
| primary_topic.subfield.display_name | Ophthalmology |
| primary_topic.display_name | Glaucoma and retinal disorders |
| related_works | https://openalex.org/W2013827304, https://openalex.org/W2266749263, https://openalex.org/W2377446268, https://openalex.org/W2138631051, https://openalex.org/W2740093133, https://openalex.org/W2144438594, https://openalex.org/W3003773491, https://openalex.org/W1994256781, https://openalex.org/W2983832527, https://openalex.org/W2163753130 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1007/s13346-024-01702-x |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764352022 |
| best_oa_location.source.issn | 2190-393X, 2190-3948 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 2190-393X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Drug Delivery and Translational Research |
| best_oa_location.source.host_organization | https://openalex.org/P4310319900 |
| best_oa_location.source.host_organization_name | Springer Science+Business Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319900 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Drug Delivery and Translational Research |
| best_oa_location.landing_page_url | https://doi.org/10.1007/s13346-024-01702-x |
| primary_location.id | doi:10.1007/s13346-024-01702-x |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2764352022 |
| primary_location.source.issn | 2190-393X, 2190-3948 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2190-393X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Drug Delivery and Translational Research |
| primary_location.source.host_organization | https://openalex.org/P4310319900 |
| primary_location.source.host_organization_name | Springer Science+Business Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319900 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Drug Delivery and Translational Research |
| primary_location.landing_page_url | https://doi.org/10.1007/s13346-024-01702-x |
| publication_date | 2024-10-03 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2761604622, https://openalex.org/W2160605010, https://openalex.org/W4249686622, https://openalex.org/W3026097277, https://openalex.org/W2076115503, https://openalex.org/W2146819974, https://openalex.org/W2924174514, https://openalex.org/W2005626802, https://openalex.org/W2333903415, https://openalex.org/W2732996930, https://openalex.org/W2803214839, https://openalex.org/W2910135651, https://openalex.org/W1983378672, https://openalex.org/W1962217919, https://openalex.org/W2152529340, https://openalex.org/W4367311300, https://openalex.org/W4391731180, https://openalex.org/W2899691980, https://openalex.org/W2984600408, https://openalex.org/W2485651500, https://openalex.org/W2536184395, https://openalex.org/W2006898897, https://openalex.org/W2083995824, https://openalex.org/W2135897976, https://openalex.org/W3030679701, https://openalex.org/W3126172682, https://openalex.org/W2030335869, https://openalex.org/W2900870690, https://openalex.org/W2012441777, https://openalex.org/W2301173095, https://openalex.org/W2592935756, https://openalex.org/W3120875631, https://openalex.org/W4392845034, https://openalex.org/W2035029504, https://openalex.org/W3128404916, https://openalex.org/W3173711838, https://openalex.org/W3214161411, https://openalex.org/W4288535238, https://openalex.org/W4389952347, https://openalex.org/W2082309056, https://openalex.org/W2560448812, https://openalex.org/W2115439624, https://openalex.org/W104245145, https://openalex.org/W2070711314, https://openalex.org/W2413982824, https://openalex.org/W4367054657, https://openalex.org/W33222008, https://openalex.org/W2240023846, https://openalex.org/W1986901350, https://openalex.org/W2063741972, https://openalex.org/W2071268436, https://openalex.org/W2758533813, https://openalex.org/W2051243541, https://openalex.org/W2047834008, https://openalex.org/W2793623156, https://openalex.org/W2026400984, https://openalex.org/W2078647260, https://openalex.org/W2913089581, https://openalex.org/W2070876833, https://openalex.org/W3205491431, https://openalex.org/W2254999921, https://openalex.org/W3214736355, https://openalex.org/W4310638952, https://openalex.org/W2003959496, https://openalex.org/W2754964393 |
| referenced_works_count | 65 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 95 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 11 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/6 |
| sustainable_development_goals[0].score | 0.8100000023841858 |
| sustainable_development_goals[0].display_name | Clean water and sanitation |
| citation_normalized_percentile.value | 0.82452956 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |